AI & Machine Learning

When a family business faced collapse, an unlikely successor returned. Now, Shuhui Mai is rebuilding it from the ground up with bold design and a new vision.

At CES 2026, Seyond debuts its Hummingbird solid-state LiDAR with a major OEM win, challenging rivals in a race to define the future of autonomy.

FeatherSnap heads to CES 2026 with its AI bird feeders, highlighting the smart home's expansion into nature, citizen science, and a competitive market.

Vivakor blames a government shutdown for its dividend delay, but shareholders are left grappling with an unusual asset and a complex CEO-related deal.

Cannabix Technologies lands its first international order for its smart breathalyzer in Australia, a move that validates its tech and reshapes its finances.

reAlpha Mortgage is offering stock ownership and AI assistants to attract loan officers, a move that could disrupt traditional industry compensation.

With a major funding round, Biobeat aims to replace bulky cuffs with a discreet patch, potentially revolutionizing hypertension care for millions.

Esports giant OverActive Media is raising fresh capital. Is this a strategic push into AI and esports dominance or a necessary move to shore up its finances?

Privately held MMMera hires strategic firm CND-SA to scale its Guillotine® gaming IP, a move highlighting the high-stakes game of professionalizing art.

With strong financials and new clinical data, medical device leader Penumbra is set to detail its growth strategy at healthcare's top investor event.

After a year of major acquisitions and AI-driven innovation, all eyes are on Labcorp's strategic vision for 2026 at the J.P. Morgan Healthcare Conference.

INVO Fertility realigns its top brass, positioning a deal-making veteran to lead an aggressive clinic acquisition strategy in a booming market.

As 10x Genomics preps for its J.P. Morgan spotlight, investors seek a clear path to profit amid fierce competition and groundbreaking innovation.

Sidus Space nets nearly $15M in a new offering to scale satellite production and defense tech, sparking investor optimism despite financial pressures.

Amidst legal industry fears of generative AI, BriefCatch's $6M funding and stellar retention prove the value of a trusted, specialized AI writing partner.

SOLAI shareholders approved a massive 30 billion share increase, arming the firm for a radical pivot into AI and the Solana ecosystem. But what about dilution?

PacBio heads to J.P. Morgan's conference with new tech aimed at making long-read sequencing cheaper. Can it challenge rivals and win over investors?

Profound Medical raises over $42M to advance its AI-powered, incision-free therapies for cancer and other diseases, signaling strong investor confidence.

As Axos sets to reveal its Q2 results, investors weigh strong growth forecasts against mounting concerns over margin pressure and a shifting economy.

As data centers face an energy crisis fueled by AI, Aradatum is commercializing a unique vertical wind turbine promising a dense, low-cost power solution.